Abstract
The surgical evolution of breast cancer treatment over the past century from Halsted through Haagensen and Urban has demonstrated the utility of radical and ultra-radical surgery. Patey, Meyer, and subsequently Fisher’s studies have initiated the movement toward surgical breast conservation. The continued progress toward lesser surgery has brought the value of axillary lymph node dissection (ALND) under close scrutiny (Frazier et al. 1977; Silverstein et al. 1987; Balch et al. 1993).
This study was supported by grant 30079 from the H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, by grant R21 CA66553-01 from the National Institutes of Health, Bethesda, Maryland, by the McDonald Douglas Research Fund, and by the Joy McCann Culverhouse Surgical Oncology Professorship of The University of South Florida Foundation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818–1822
Balch CM, Singletary ES, Bland KI (1993) Clinical decision-making in early breast cancer. Ann Surg 217:207–225
Cady B (1994) The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 73:505–508
Danforth DN Jr, Findlay PA, MacDonald HD et al (1986) Complete axillary lymph node dissection for stage I–II carcinoma of the breast. J Clin Oncol 4:655–662
Davies GC, Millis RR, Hayward JL (1980) Assessment of axillary lymph node status. Ann Surg 192:148–151
Dees EC, Shulman LN, Souba WW, Smith BL (1997) Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? Ann Surg 226:279–286
Fisher B, Wolmak N, Bauer M et al (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152:765–772
Frazier TG, Copeland EM, Gallaher HS, Paulus DD Jr, White EC (1977) Prognosis and treatment in minimal breast cancer. Am J Surg 133:697–701
Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–401
Giuliano AE, Jones RC, Brennan M et al (1997) Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345–2350
Guenther JM, Krishnamoorthy M, Tan LR (1997) Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 3:336–340
International (Ludwig) Breast Cancer Study Group (1990) Prognostic importance of occult axillary lymph node micrometastatses from breast cancers. Lancet 335:1565–1568
Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66:136–138
Krag DN, Weaver DL, Alex JC et al (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335–339
Moffatt FL, Senofsky GM, Davis K et al (1992) Axillary node dissection for early breast cancer: some is good but all is better. J Surg Oncol 51:8–13
Morton DL, Wen DR, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399
National Institutes of Health (1992) Consumers Development Conference: National Institute of Health Consensus Statement 8:1–19
Neiweg DE, Kapteijn BA, Petuse JL et al (1996) Identification of the sentinel node in patients with breast carcinoma. Ned Tidschr Geneeskd 140:2235–2239
Pijpers R, Meijer S, Hoekstra OS et al (1997) Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 38:366–368
Ravdin PM, DeLaurentiis M, Vendely T, Clark GM (1994) Production of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Nat Cancer Inst 86:1771–1775
Recht A, Houlihan MJ (1995) Axillary lymph nodes and breast cancer: a review. Cancer 76:1491–1512
Schneebaum S, Stadler Y, Cohen M et al (1996) Sentinel lymph node localization in breast cancer: a feasibility study. Society of Surgical Oncology (SSO) Meeting, March 21–24, Atlanta, GA Upstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol (in press)
Silverstein MJ, Rosser RJ, Gierson ED et al (1987) Axillary lymph node dissection for intraductal carcinoma: is it indicated? Cancer 59:1819–1824
Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P (1994) Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 73:661–664
Veronesi U, Paganelli G, Galimberti V, Viale G et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 349:1864–1867
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Cox, C.E. et al. (1998). Sentinel Lymphadenectomy: A Safe Answer to Less Axillary Surgery?. In: Senn, HJ., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Primary Breast Cancer VI. Recent Results in Cancer Research, vol 152. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45769-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-45769-2_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45771-5
Online ISBN: 978-3-642-45769-2
eBook Packages: Springer Book Archive